Earnings
DORM
132.49
+0.90%
1.18
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
2.01B
2.01B
--
1.20B
806.36M
513.45M
481.35M
32.10M
--
--
--
--
292.91M
-39.73M
--
3.07M
256.25M
66.25M
190.00M
--
--
--
190.00M
--
190.00M
--
190.00M
190.00M
--
190.00M
30.96M
6.14
6.14
--
6.14
FY 2023
1.93B
1.93B
--
1.24B
685.42M
470.66M
438.36M
32.30M
--
--
--
--
214.76M
-48.06M
--
1.80M
168.50M
39.24M
129.26M
--
--
--
129.26M
--
129.26M
--
129.26M
129.26M
--
129.26M
31.53M
4.10
4.10
--
4.10
FY 2022
1.73B
1.73B
--
1.17B
564.45M
393.40M
368.60M
24.80M
--
--
--
--
171.05M
-15.58M
--
735.00K
156.20M
34.65M
121.55M
--
--
--
121.55M
--
121.55M
--
121.55M
121.55M
--
121.55M
31.54M
3.85
3.85
--
3.85
FY 2021
1.35B
1.35B
--
882.33M
462.92M
291.37M
268.26M
23.10M
--
--
--
--
171.55M
-2.16M
--
377.00K
169.77M
38.23M
131.53M
--
--
--
131.53M
--
131.53M
--
131.53M
131.53M
--
131.53M
31.96M
4.12
4.12
--
4.12
FY 2020
1.09B
1.09B
--
709.63M
383.12M
249.74M
229.04M
20.70M
--
--
--
--
133.37M
--
--
2.36M
135.74M
28.87M
106.87M
--
--
--
106.87M
--
106.87M
--
106.87M
106.87M
--
106.87M
32.37M
3.30
3.30
--
3.30

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.